Drug Profile
PF 904
Latest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Almirall-Prodesfarma
- Class Antiasthmatics; Bronchodilators; Pyrazines; Thiadiazines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 20 Dec 1996 Phase-I clinical trials for Asthma in Spain (Unknown route)
- 02 Mar 1995 Preclinical development for Asthma in Spain (Unknown route)